When VHL-induced degradation is impaired, HIF1A and HIF2A accumulate, resulting in elevated levels of erythropoietin (EPO), vascular endothelial growth factor (VEGF), and other growth factors, which promote tumor growth [11,12,13]. This evidence concerns the gene EPO and neoplasm.